세계의 웨스트 증후군 시장 보고서(2025년)

West Syndrome Global Market Report 2025

US $ 4,490 ￦ 6,319,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,134,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,949,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

웨스트 증후군 시장 규모는 향후 몇 년간 강력한 성장이 예상됩니다. 정밀 의학의 발전, 링 디바이스의 가용성 증가, 희귀질환 보조금 확대, 빅데이터 분석 통합, 약물전달 시스템의 혁신, 희귀질환에 대한 희귀 질환에 대한 글로벌 보건 이니셔티브에 의해 주도될 것입니다. 주요 동향으로는 AI에 의한 뇌파 해석, 휴대용 및 웨어러블 발작 모니터링 장치, 예측 진단을 위한 머신러닝, 유전자 검사를 위한 차세대 시퀀서, 클라우드 기반의 데이터 공유 플랫폼, 비침습적 뇌 자극 기술, 실시간 원격 모니터링 툴, 증상 추적을 위한 디지털 건강 앱이 포함됩니다. 뇌 모델 연구를 위한 3D 바이오프린팅, 그리고 보안 환자 데이터 관리를 위한 블록체인이 있습니다.

신경질환의 연구개발 투자 증가는 앞으로 수년간 웨스트 증후군 시장의 성장을 가속할 것으로 예측됩니다. 신경질환의 연구개발비는 신경질환의 이해, 진단, 치료의 진보를 지원하고 있습니다. 신경계 질환의 유병률 증가, 의료 과학 기술 발전, 인식 증대, 혁신적인 치료법에 대한 수요, 그리고 정부 및 민간 부문으로부터의 상당한 재정적 지원 등이 연구 개발 지출 증가의 원인으로 지목됩니다. 자금 증가는 진단, 치료 및 치료 옵션의 진보를 촉진하고 웨스트 증후군 시장의 확대에 기여합니다. 예를 들어 2023년 5월 미국 국립위생연구소(National Institutes of Health) 산하의 정부기관인 국립신경질환 및 뇌졸중연구소(National Institute of Neurological Disorders and Stroke: NINDS)는 광범위한 신경학적 연구 이니셔티브를 지원하기 위해 28억 900만 달러의 자금을 받았으며, 2024년에는 28억 2,500만 달러로 소폭 증가한 예산을 요청했습니다. 그 결과, 신경질환에 대한 R&D 투자의 확대가 웨스트 증후군 시장의 성장을 가속하고 있습니다.

웨스트 증후군 시장의 주요 기업은 비가바트린의 바로 사용할 수 있는 경구용액 등 혁신적인 치료법의 개발을 우선하고 있어 투여의 간편성을 높이고 정확한 투여를 보장하며 유아의 치료 어드히어런스를 향상시키고 있습니다. 이러한 제형은 비가바트린 및 부신피질자극호르몬(ACTH)과 같은 항간질제를 환자에게 친화적인 방식으로 투여할 수 있도록 설계되었습니다. 이로스 퍼머슈티칼스사는 소아 경련의 치료제으로서 곧바로 사용할 수 있는 비가바트린의 내복액의 승인을 식품의약국(FDA)으로부터 취득했습니다. 비가바트린(Vigabatrin)은 뇌에서 감마-아미노뷰티르산(GABA)을 분해하는 효소인 GABA 트랜스아미나제(GABA-T)를 돌이킬 수 없게 저해함으로써 작용합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 웨스트 증후군 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계 웨스트 증후군 시장 : 성장률 분석
• 세계 웨스트 증후군 시장 실적 : 규모와 성장, 2019-2024
• 세계 웨스트 증후군 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 웨스트 증후군 전체 시장 규모(TAM)

제6장 시장 세분화

• 세계의 웨스트 증후군 시장 : 치료별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 항경련제
• 벤조디아제핀
• 코르티코스테로이드
• 비타민 B
• 세계의 웨스트 증후군 시장 : 투여 경로별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 비경구 경로
• 경구 경로
• 기타 투여 경로
• 세계의 웨스트 증후군 시장 : 유통 채널별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 병원 약국
• 온라인 약국
• 소매 약국
• 세계의 웨스트 증후군 시장 : 최종 사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 병원
• 홈케어
• 클리닉
• 세계의 웨스트 증후군 시장 : 항간질약유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 종래의 항간질약
• 새로운 항 간질 약
• 세계의 웨스트 증후군 시장 : 벤조디아제핀유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 디아제팜
• 로라제팜
• 크로나제팜
• 세계의 웨스트 증후군 시장 : 코르티코스테로이드유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 프레드니솔론
• 부신피질자극호르몬(ACTH)
• 덱사메타손
• 세계의 웨스트 증후군 시장 : 비타민 B별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 비타민 B6(피리독신)
• 비타민 B12(코발라민)

제7장 지역별/국가별 분석

• 세계의 웨스트 증후군 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 웨스트 증후군 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 웨스트 증후군 시장 : 경쟁 구도
• 웨스트 증후군 시장 : 기업 프로파일
  • Takeda Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
  • Jazz Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
  • UCB SA Overview, Products and Services, Strategy and Financial Analysis
  • H. Lundbeck A/S Overview, Products and Services, Strategy and Financial Analysis
  • Mallinckrodt Pharmaceuticals plc Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업 및 혁신 기업

• Harmony Biosciences Holdings Inc.
• Nutricia(Ketogenic diet) Ltd.
• Upsher-Smith Laboratories LLC
• Catalyst Pharmaceuticals Inc.
• SK Biopharmaceuticals Co. Ltd.
• Cedars Sinai Health System
• Marinus Pharmaceuticals Inc.
• Biocodex SA
• BioPharm Solutions Inc.
• Cerecin Inc.
• GW Pharmaceuticals Limited
• Anavex Life Sciences Corp
• Bio-Pharm Solutions
• Ovid Therapeutics Inc.
• Epygenix Therapeutics Inc.

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

• 웨스트 증후군 시장(2029년) : 새로운 기회를 제공하는 국가
• 웨스트 증후군 시장(2029년) : 새로운 기회를 제공하는 부문
• 웨스트 증후군 시장(2029년) : 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제36장 부록

SHW

영문 목차

영문목차

West syndrome, also known as infantile spasms, is a rare neurological disorder that typically affects infants within their first year of life. It is characterized by sudden muscle contractions occurring in clusters, abnormal brain wave patterns known as hypsarrhythmia, and developmental regression or stagnation. If left untreated, West syndrome can lead to long-term cognitive and motor impairments.

The primary treatments for West syndrome include anticonvulsants, benzodiazepines, corticosteroids, and vitamin B. Anticonvulsants are a class of drugs designed to prevent or reduce the severity and frequency of seizures in individuals with epilepsy or other seizure disorders, including infantile spasms. The available routes of administration include the parenteral route, oral route, and others. West syndrome treatments are distributed through hospital pharmacies, online pharmacies, and retail pharmacies, serving end users such as hospitals, home care, and clinics.

The west syndrome market research report is one of a series of new reports from The Business Research Company that provides west syndrome market statistics, including west syndrome industry global market size, regional shares, competitors with a west syndrome market share, detailed west syndrome market segments, market trends and opportunities, and any further data you may need to thrive in the west syndrome industry. This west syndrome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The west syndrome market size has grown strongly in recent years. It will grow from $1.02 billion in 2024 to $1.11 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth during the historic period can be attributed to increasing awareness of rare diseases, the introduction of ACTH therapy, the development of vigabatrin, a rise in genetic studies, the establishment of pediatric neurology centers, the expansion of orphan drug programs, early adoption of the ketogenic diet, and support from advocacy groups.

The west syndrome market size is expected to see strong growth in the next few years. It will grow to $1.40 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The projected growth in the forecast period is driven by advancements in precision medicine, increasing availability of wearable seizure monitoring devices, expansion of rare disease funding, integration of big data analytics, innovations in drug delivery systems, global health initiatives for rare conditions, and a greater focus on pediatric healthcare infrastructure. Key trends include AI-assisted EEG analysis, portable and wearable seizure monitoring devices, machine learning for predictive diagnosis, next-generation sequencing for genetic testing, cloud-based data-sharing platforms, non-invasive brain stimulation technologies, real-time remote monitoring tools, digital health apps for symptom tracking, 3D bioprinting for brain model research, and blockchain for secure patient data management.

The increasing investment in research and development for neurological disorders is expected to drive the growth of the West syndrome market in the coming years. Research and development funding for neurological illnesses supports advancements in understanding, diagnosing, and treating neurological conditions. The rise in research and development spending is attributed to the growing prevalence of neurological disorders, technological advancements in medical science, increasing awareness, demand for innovative treatments, and substantial financial support from both government and private sectors. Increased funding drives progress in diagnostics, therapies, and treatment options, contributing to the expansion of the West syndrome market. For example, in May 2023, the National Institute of Neurological Disorders and Stroke (NINDS), a US-based government agency under the National Institutes of Health, received $2.809 billion in funding, with a slight increase to $2.825 billion requested for 2024 to support a wide range of neurological research initiatives. Consequently, the growing research and development investment in neurological illnesses is fostering the growth of the West syndrome market.

Leading companies in the west syndrome market are prioritizing the development of innovative treatments, such as ready-to-use oral solutions of vigabatrin, to enhance ease of administration, ensure accurate dosing, and improve treatment adherence in infants and young children. These formulations are designed to facilitate the delivery of antiepileptic medications, including vigabatrin and adrenocorticotropic hormone (ACTH), in a patient-friendly manner. For instance, in June 2024, Pyros Pharmaceuticals, a US-based pharmaceutical company, received approval from the Food and Drug Administration (FDA) for a ready-to-use oral solution of vigabatrin to treat infantile spasms. Vigabatrin works by irreversibly inhibiting GABA transaminase (GABA-T), the enzyme responsible for breaking down gamma-aminobutyric acid (GABA) in the brain. The resulting increase in GABA levels helps suppress the excessive excitatory processes that can trigger seizures.

In December 2024, H. Lundbeck A/S, a Denmark-based pharmaceutical company, acquired Longboard Pharmaceuticals Inc. for $2.6 billion. Through this acquisition, Lundbeck gained access to bexicaserin, a 5-HT2C agonist in development for treating seizures associated with developmental and epileptic encephalopathies (DEEs), including Dravet syndrome, Lennox-Gastaut syndrome, and other rare epilepsies. Longboard Pharmaceuticals Inc. is a US-based clinical-stage biopharmaceutical company specializing in therapies for seizures related to developmental and epileptic encephalopathies (DEEs), including West syndrome.

Major players in the west syndrome market are Takeda Pharmaceuticals, Jazz Pharmaceuticals, UCB S.A., H. Lundbeck A/S, Mallinckrodt Pharmaceuticals plc, Harmony Biosciences Holdings Inc., Nutricia (Ketogenic diet) Ltd., Upsher-Smith Laboratories LLC, Catalyst Pharmaceuticals Inc., SK Biopharmaceuticals Co. Ltd., Cedars Sinai Health System, Marinus Pharmaceuticals Inc., Biocodex S.A., BioPharm Solutions Inc., Cerecin Inc., GW Pharmaceuticals Limited, Anavex Life Sciences Corp, Bio-Pharm Solutions, Ovid Therapeutics Inc., Epygenix Therapeutics Inc., Amzell.

North America was the largest region in the west syndrome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in west syndrome report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the west syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The west syndrome market consists of revenues earned by entities by providing services such as neuroimaging technologies, genetic testing services, rehabilitative services, specialized dietary programs, supportive care and patient counseling for managing infantile spasms and associated developmental delays. The market value includes the value of related goods sold by the service provider or included within the service offering. The west syndrome market includes sales of hormone therapies, ketogenic diet and developmental therapies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

West Syndrome Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on west syndrome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for west syndrome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The west syndrome market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment: Anticonvulsant; Benzodiazepine; Corticosteroids; Vitamin B
• 2) By Route Of Administration: Parenteral Route; Oral Route; Other Routes Of Administration
• 3) By Distribution Channel: Hospitals Pharmacies; Online Pharmacies; Retail Pharmacies
• 4) By End-User: Hospitals; Homecare; Clinics
• Subsegments:
• 1) By Anticonvulsant: Traditional Anticonvulsants; Newer Anticonvulsants
• 2) By Benzodiazepine: Diazepam; Lorazepam; Clonazepam
• 3) By Corticosteroids: Prednisolone; Adrenocorticotropic Hormone (ACTH); Dexamethasone
• 4) By Vitamin B: Vitamin B6 (Pyridoxine); Vitamin B12 (Cobalamin)
• Companies Mentioned: Takeda Pharmaceuticals; Jazz Pharmaceuticals; UCB S.A.; H. Lundbeck A/S; Mallinckrodt Pharmaceuticals plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. West Syndrome Market Characteristics

3. West Syndrome Market Trends And Strategies

4. West Syndrome Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global West Syndrome Growth Analysis And Strategic Analysis Framework

• 5.1. Global West Syndrome PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global West Syndrome Market Growth Rate Analysis
• 5.4. Global West Syndrome Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global West Syndrome Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global West Syndrome Total Addressable Market (TAM)

6. West Syndrome Market Segmentation

• 6.1. Global West Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anticonvulsant
• Benzodiazepine
• Corticosteroids
• Vitamin B
• 6.2. Global West Syndrome Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Parenteral Route
• Oral Route
• Other Routes Of Administration
• 6.3. Global West Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals Pharmacies
• Online Pharmacies
• Retail Pharmacies
• 6.4. Global West Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Clinics
• 6.5. Global West Syndrome Market, Sub-Segmentation Of Anticonvulsant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Traditional Anticonvulsants
• Newer Anticonvulsants
• 6.6. Global West Syndrome Market, Sub-Segmentation Of Benzodiazepine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diazepam
• Lorazepam
• Clonazepam
• 6.7. Global West Syndrome Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prednisolone
• Adrenocorticotropic Hormone (ACTH)
• Dexamethasone
• 6.8. Global West Syndrome Market, Sub-Segmentation Of Vitamin B, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vitamin B6 (Pyridoxine)
• Vitamin B12 (Cobalamin)

7. West Syndrome Market Regional And Country Analysis

• 7.1. Global West Syndrome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global West Syndrome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific West Syndrome Market

• 8.1. Asia-Pacific West Syndrome Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific West Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific West Syndrome Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific West Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China West Syndrome Market

• 9.1. China West Syndrome Market Overview
• 9.2. China West Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China West Syndrome Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China West Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India West Syndrome Market

• 10.1. India West Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India West Syndrome Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India West Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan West Syndrome Market

• 11.1. Japan West Syndrome Market Overview
• 11.2. Japan West Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan West Syndrome Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan West Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia West Syndrome Market

• 12.1. Australia West Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia West Syndrome Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia West Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia West Syndrome Market

• 13.1. Indonesia West Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia West Syndrome Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia West Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea West Syndrome Market

• 14.1. South Korea West Syndrome Market Overview
• 14.2. South Korea West Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea West Syndrome Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea West Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe West Syndrome Market

• 15.1. Western Europe West Syndrome Market Overview
• 15.2. Western Europe West Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe West Syndrome Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe West Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK West Syndrome Market

• 16.1. UK West Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK West Syndrome Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK West Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany West Syndrome Market

• 17.1. Germany West Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany West Syndrome Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany West Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France West Syndrome Market

• 18.1. France West Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France West Syndrome Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France West Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy West Syndrome Market

• 19.1. Italy West Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy West Syndrome Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy West Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain West Syndrome Market

• 20.1. Spain West Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain West Syndrome Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain West Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe West Syndrome Market

• 21.1. Eastern Europe West Syndrome Market Overview
• 21.2. Eastern Europe West Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe West Syndrome Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe West Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia West Syndrome Market

• 22.1. Russia West Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia West Syndrome Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia West Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America West Syndrome Market

• 23.1. North America West Syndrome Market Overview
• 23.2. North America West Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America West Syndrome Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America West Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA West Syndrome Market

• 24.1. USA West Syndrome Market Overview
• 24.2. USA West Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA West Syndrome Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA West Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada West Syndrome Market

• 25.1. Canada West Syndrome Market Overview
• 25.2. Canada West Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada West Syndrome Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada West Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America West Syndrome Market

• 26.1. South America West Syndrome Market Overview
• 26.2. South America West Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America West Syndrome Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America West Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil West Syndrome Market

• 27.1. Brazil West Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil West Syndrome Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil West Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East West Syndrome Market

• 28.1. Middle East West Syndrome Market Overview
• 28.2. Middle East West Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East West Syndrome Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East West Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa West Syndrome Market

• 29.1. Africa West Syndrome Market Overview
• 29.2. Africa West Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa West Syndrome Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa West Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. West Syndrome Market Competitive Landscape And Company Profiles

• 30.1. West Syndrome Market Competitive Landscape
• 30.2. West Syndrome Market Company Profiles
  • 30.2.1. Takeda Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Jazz Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. UCB S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. H. Lundbeck A/S Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Mallinckrodt Pharmaceuticals plc Overview, Products and Services, Strategy and Financial Analysis

31. West Syndrome Market Other Major And Innovative Companies

• 31.1. Harmony Biosciences Holdings Inc.
• 31.2. Nutricia (Ketogenic diet) Ltd.
• 31.3. Upsher-Smith Laboratories LLC
• 31.4. Catalyst Pharmaceuticals Inc.
• 31.5. SK Biopharmaceuticals Co. Ltd.
• 31.6. Cedars Sinai Health System
• 31.7. Marinus Pharmaceuticals Inc.
• 31.8. Biocodex S.A.
• 31.9. BioPharm Solutions Inc.
• 31.10. Cerecin Inc.
• 31.11. GW Pharmaceuticals Limited
• 31.12. Anavex Life Sciences Corp
• 31.13. Bio-Pharm Solutions
• 31.14. Ovid Therapeutics Inc.
• 31.15. Epygenix Therapeutics Inc.

32. Global West Syndrome Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The West Syndrome Market

34. Recent Developments In The West Syndrome Market

35. West Syndrome Market High Potential Countries, Segments and Strategies

• 35.1 West Syndrome Market In 2029 - Countries Offering Most New Opportunities
• 35.2 West Syndrome Market In 2029 - Segments Offering Most New Opportunities
• 35.3 West Syndrome Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료